The exchanger inhibitory peptide region-dependent inhibition of Na +/Ca2+ exchange by SN-6 [2-[4-(4-nitrobenzyloxy)benzyl]- thiazolidine-4-carboxylic acid ethyl ester], a novel benzyloxyphenyl derivative

Molecular Pharmacology

Volumn 66, Issue 1, 2004, Pages 45-55

  Iwamoto, Takahiro ^a,b   Inoue, Yutaka ^c   Ito, Kazuhiko ^c   Sakaue, Takahiro ^c   Kita, Satomi ^a   Katsuragi, Takeshi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c SENJU PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (4 NITROBENZYLOXY)BENZYL]THIAZOLIDINE 4 CARBOXYLIC ACID ETHYL ESTER; BENZYLOXYPHENYL DERIVATIVE; CALCIUM ION; DRUG RECEPTOR; PROTEIN INHIBITOR; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CALCIUM EXCHANGE PROTEIN 1; SODIUM CALCIUM EXCHANGE PROTEIN 2; SODIUM CALCIUM EXCHANGE PROTEIN 3; SODIUM ION; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL HYPOXIA; CELL PROTECTION; CHIMERA; CHINESE HAMSTER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG RESPONSE; DRUG SENSITIVITY; DRUG STRUCTURE; EXCHANGER INHIBITORY PEPTIDE REGION; FIBROBLAST; GENE MUTATION; GENETIC TRANSFECTION; IC 50; KIDNEY TUBULE CELL; LUNG FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; REOXYGENATION; REPERFUSION INJURY; SITE DIRECTED MUTAGENESIS; SODIUM CALCIUM EXCHANGE; SODIUM CELL LEVEL;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANOXIA; BENZYL COMPOUNDS; CELLS, CULTURED; CRICETINAE; CRICETULUS; KIDNEY DISEASES; PEPTIDES; PROTECTIVE AGENTS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; SODIUM-CALCIUM EXCHANGER; THIAZOLES; THIAZOLIDINES;

EID: 3042579803     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.66.1.45     Document Type: Article

References (40)

1. Bers DM (2002) Cardiac excitation-contraction coupling. Nature (Lond) 415:198-205.
2. Blaustein MP and Lederer WJ (1999) Sodium/calcium exchange: its physiological implications. Physiol Rev 79:763-854.
3. 2+ exchangers with altered ionic regulation. Mol Pharmacol 65: 802-810.
4. Condrescu M, Gardner JP, Chernaya G, Aceto JF, Kroupis C, and Reeves JP (1995) ATP-dependent regulation of sodium-calcium exchange in Chinese hamster ovary cells transfected with the bovine cardiac sodium-calcium exchanger. J Biol Chem 270:9137-9146.
5. 2+ exchanger. J Biol Chem 273:778-783.
6. 2+ exchange by KB-R7943: transport mode selectivity and antiarrhythmic consequences. Am J Physiol 281:H1334-H1345.
7. Haworth RA, Goknur AB, Hunter DR, Hegge JO, and Berkoff HA (1987) Inhibition of calcium influx in isolated adult rat heart cells by ATP depletion. Circ Res 60:586-594.
8. Hilgemann DW (1997) Cytoplasmic ATP-dependent regulation of ion transporters and channels: mechanisms and messengers. Annu Rev Physiol 59:193-220.
9. Hilgemann DW, Collins A, and Matsuoka S (1992a) Steady-state and dynamic properties of cardiac sodium-calcium exchange. Secondary modulation by cytoplasmic calcium and ATP. J Gen Physiol 100:933-961.
10. Hilgemann DW, Matsuoka S, Nagel GA, and Collins A (1992b) Steady-state and dynamic properties of cardiac sodium-calcium exchange. Sodium-dependent inactivation. J Gen Physiol 100:905-932.
11. 2+ exchange inhibitor, on ischemia-reperfusion-injured hearts. Jpn J Pharmacol 88(Suppl):257P.
12. 2+ exchanger using novel drugs and genetically engineered mice. Folia Pharmacol Jpn 120:91P-93P.
13. 2+ exchange (NCX1) inhibition by SEA0400. J Biol Chem 279:7544-7553.
14. 2+ exchanger. Mol Pharmacol 59:524-531.
15. 2+ exchanger. FEBS Lett 446:264-268.
16. 2+ exchanger isoforms NCX1 and NCX3 does not require their direct phosphorylation. Biochemistry 37:17230-17238.
17. 2+ affinity. J Biol Chem 275:38571-38580.
18. +. J Biol Chem 274:23094-23102.
19. 2+ exchange in cells expressing NCX1. J Biol Chem 271:22391-22397.
20. 2+ exchanger. J Biol Chem 269:22847-22852.
21. 2+ exchanger. J Biol Chem 286:1014-1020.
22. 3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. J Pharmacol Exp Ther 228:648-655.
23. 2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J Pharmacol Exp Ther 298:249-256.
24. 2+ exchanger by the endogenous XIP region. J Gen Physiol 109:273-286.
25. 2+-binding domain. J Gen Physiol 105:403-420.
26. 2+ exchange inhibitor, on myocardial ischemia/reperfusion injury. Folia Pharmacol Jpn 111:105-115.
27. 2+ exchanger. J Biol Chem 271:13385-13391.
28. 2+ exchanger. J Biol Chem 274:910-917.
29. 2+ exchange inhibitor, SEA0400, improves ischemia/reperfusion-induced renal injury. Eur J Pharmacol 478:187-198.
30. Philipson KD and Nicoll DA (2000) Sodium-calcium exchange: a molecular perspective. Annu Rev Physiol 62:111-133.
31. 2+ exchange inhibitor KB-R7943 also blocks native and expressed neuronal nicotinic receptors. Br J Pharmacol 130:1893-1902.
32. 2+ exchanger. J Biol Chem 276:194-199.
33. 2+ exchanger isoforms NCX1, NCX2 and NCX3 in rat. Am J Physiol 272:C1250-C1261.
34. 2+ exchange inhibitors. Circ Res 91:90-92.
35. 2+ exchange: molecular and pharmacological aspects. Circ Res 88:864-876.
36. 2+ exchange inhibitor KB-R7943. Neuropharmacology 38:1235-1242.
37. 2+ exchanger, on myocardial ischemia-reperfusion injuries. Eur J Pharmacol 458:155-162.
38. 2+ overload in reperfused ischemic myocardium. Annu Rev Physiol 52:543-559.
39. 2+ exchange current in guinea-pig cardiac ventricular cells. Br J Pharmacol 119:555-563.
40. 2+ exchanger. J Pharmacol Exp Ther 304:284-293.